Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Astrocytes in multiple sclerosis.
Cross-disease transcriptomics: Unique IL-17A signaling in psoriasis lesions and an autoimmune PBMC signature.
Sunshine, Sea, and Season of Birth: MS Incidence in Wales.
Making Treatment & Lifestyle Decisions: Thinking About Benefits & Risks
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
Olfactory dysfunction in patients with multiple sclerosis.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Defining the clinical course of multiple sclerosis: The 2013 revisions.
Histologie de la sclerose en plaques
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
MS research gears up for new drugs
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.
Histamine and Immune Biomarkers in CNS Disorders.
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Preferential Use of Public TCR during Autoimmune Encephalomyelitis.
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients.
Pediatric Optic Neuritis Prospective Outcomes Study.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies.
BIIB033 single ascending dose study in healthy volunteer subjects
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.